


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-6.63%
-14.64%
+4.21%
-3.16%
+2.16%
VTRS
Viatris
$13.68
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Risk Analysis

Investors losing their confidence
VTRS Price Performance
$12.37 (+10.59%)
$10.76 (+27.14%)
$10.45 (+30.91%)
$10.86 (+25.97%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
VTRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VTRS Street Sentiment is extremely bullish and have negative views on the near-term outlook
VTRS has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 06, 2026
Upgrade
Buy
Zacks
Dec 30, 2025
Initiate
Buy
Barclays
Dec 10, 2025
Initiate
Overweight
Barclays
Oct 24, 2025
Initiate
Buy
Truist
Oct 15, 2025
Initiate
Buy
Truist Securities
TBPH
Theravance Biopharma
19.99
+0.81%
INDV
Indivior PLC
35.45
+1.29%
PRFX
PainReform Ltd.
0.68
+1.01%
PFE
Pfizer
25.77
-3.34%
NVS
Novartis AG
149.86
-0.78%
VTRS
Viatris
13.68
0.00%
ANNX
Annexon
6.48
+1.57%
MDB
MongoDB
346.06
-7.14%
BTDR
Bitdeer Technologies Grou
12.96
-1.74%
TER
Teradyne
282.98
+13.41%
What is VTRS current stock price?
What are VTRS stock strengths?
What is VTRS Risk Level?
What is VTRS market cap and volume?
What is VTRS current Stock IQ?
Should I buy VTRS stock right now?
Is VTRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for VTRS?
What does a 'Strong Sell' rating mean for VTRS?
What factors influence VTRS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.63%
-14.64%
+4.21%
-3.16%
+2.16%
VTRS
Viatris
Current Price
$13.68
Linked to VTRS
TBPH
Theravance Biopharma
19.99
+0.81%
INDV
Indivior PLC
35.45
+1.29%
PRFX
PainReform Ltd.
0.68
+1.01%
PFE
Pfizer
25.77
-3.34%
NVS
Novartis AG
149.86
-0.78%
Recently Viewed
VTRS
Viatris
13.68
0.00%
ANNX
Annexon
6.48
+1.57%
MDB
MongoDB
346.06
-7.14%
BTDR
Bitdeer Technologies Grou
12.96
-1.74%
TER
Teradyne
282.98
+13.41%

VTRS Price Performance
$12.37 (+10.59%)
$10.76 (+27.14%)
$10.45 (+30.91%)
$10.86 (+25.97%)
VTRS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
VTRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
VTRS Street Sentiment is extremely bullish and have negative views on the near-term outlook
VTRS has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 06, 2026
Upgrade
Buy
Zacks
Dec 30, 2025
Initiate
Buy
Barclays
Dec 10, 2025
Initiate
Overweight
Barclays
Oct 24, 2025
Initiate
Buy
Truist
Oct 15, 2025
Initiate
Buy
Truist Securities
VTRS Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Risk Analysis

Investors losing their confidence
VTRS Latest Analysis
What Does the Market Think About Viatris Inc?. VTRS) short interest as a percent of float has fallen 21.58% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.Short ...
Thu Jan 29, 2026
Viatris Launches Inpefa To Treat Heart Failure In UAE . (RTTNews) - Viatris Inc. (VTRS) a healthcare company Tuesday announced the launch of Inpefa or sotagliflozin in the United Arab Emirates or UAE which is the first country within the Viatris territories to commercialize this treatment.
Tue Jan 20, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VTRS Stock trends
VTRS Stock performance
VTRS Stock analysis
VTRS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.